Gu Zheyi

Partner

5 past transactions

4C Medical Technologies

Series D in 2025
4C Medical Technologies is a medical device company focused on developing minimally invasive therapies for structural heart disease, including treatments for mitral regurgitation that preserve the native mitral valve and left ventricle while addressing limitations of transcatheter approaches. Its AltaValve system uses supra-annular positioning with atrial-only fixation to treat MR without disturbing the native mitral annulus or LV, offering a less invasive alternative that maintains native anatomy and ventricular function. Founded in 2015 and based in Maple Grove, Minnesota, the company advances therapies intended to improve access to treatment for complex structural heart conditions.

BIODEP

Venture Round in 2024
Biodep is a Chinese biotechnology company based in Wuxi, dedicated to producing probiotics and their derivatives. These products are utilized across various industries including food processing, health foods, cosmetics, environmental remediation, modern agriculture, and others.

AccuPath

Venture Round in 2023
AccuPath is a high-tech group dedicated to enhancing human life and health via the use of modern materials & manufacturing science and technology.

Rongmai Medical

Seed Round in 2023
Rongmai Medical is a producer of medical devices for peripheral vascular interventions.

BIODEP

Venture Round in 2023
Biodep is a Chinese biotechnology company based in Wuxi, dedicated to producing probiotics and their derivatives. These products are utilized across various industries including food processing, health foods, cosmetics, environmental remediation, modern agriculture, and others.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.